TLSI Chief Medical Officer Henry Buys 120,000 Shares

Marshall Richard Henry, the Chief Medical Officer of TLSI, made a significant move by purchasing 120,000 shares of the company on June 29, 2026. This insider buying activity is notable as it shows confidence in the company's future.

Insider Buying and Selling at TriSalus Life Sciences, Inc.

On June 29, 2026, Marshall Richard Henry, TLSI's Chief Medical Officer, purchased 120,000 shares. Earlier that day, he also bought 60,000 shares. These transactions were not part of a pre-arranged trading plan. Meanwhile, on May 15, 2026, Richard Marshak, the Chief Commercial Officer, sold 543 shares at $2.67 each.

Other Institutional Activity in TLSI

First Light Asset Management opened a new position in TLSI, acquiring 5,066,827 shares valued at approximately $20.3 million. AWM Investment Company increased its holdings by 835,325 shares, reaching a total of 2,079,105 shares worth about $8.3 million, marking a 67.2% increase. Nantahala Capital Management held steady with 2,070,827 shares valued at $8.3 million. BlackRock trimmed its position by 34,789 shares, ending with 1,499,547 shares valued at around $6 million, a 2.3% decrease.

TriSalus Life Sciences, Inc. Stock Down 7.1%

Shares of TLSI traded near $4.74 on Tuesday. The company's stock has been drawing attention due to recent insider buying and institutional interest.

Analysts Set New Price Targets

On May 13, 2026, Lake Street maintained a 'buy' rating for TLSI with a price target of $8. Canaccord Genuity also maintained a 'buy' rating with a price target of $7, reiterated on March 9, 2026. The consensus among analysts is positive, with a 'buy' rating and an average price target reflecting optimism about TLSI's potential.

Bottom Line

The recent insider buying by Marshall Richard Henry suggests confidence in TLSI's prospects. Institutional interest further underscores this sentiment, as several funds have either opened new positions or increased their holdings. While these activities are positive indicators, it's important to remember that 13F filings and insider trades are backward-looking and may not reflect the current situation.